The neutrophil/lymphocyte ratio in predicting outcome for hospitalized patients with community-acquired pneumonia Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014
²Many-armed" CD4: Why it is necessary to count blood CD4 at patient with severe community-acquired pneumonia (CAP)? Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
Prognostic factors of 30 day mortality in HIV infected patients with community-acquired pneumonia Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014
The impact of mixed etiology in community acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014
Drug-resistant pathogens prediction scores in CAP, HCAP and immunocompromised Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015
Physical deterioration during hospitalization in patients with community-acquired pneumonia Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions Year: 2015
Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013
Bacteremia in non-HIV community acquired pneumonia Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013
Shortening duration of antibiotic therapy according to clinical stability in patients with community-acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014
The outcome of community-acquired pneumonia in patients with COPD, asthma and ILD - a case-control study Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Platelet count is a marker of outcome in community-acquired pneumonia Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013
Immunoglobulin levels and severity of community-acquired pneumonia (CAP) Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014
30 day mortality and eosinopenia in patients with pneumonia Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014
Clinical and radiological features of pneumocystis pneumonia in immunocompromised non-HIV patients Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016
Multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia Source: Annual Congress 2013 –Recent developments in pneumonia Year: 2013
Microbial aetiology and outcomes of CAP in bronchiectatic patients Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013
Community-acquired pneumonia in outpatients: aetiology and outcomes}, Source: Eur Respir J 2012; 40: 931-938 Year: 2012
Healthcare-associated pneumonia: Comparative characteristics with community-acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015
Clinical pattern of LRTI with RSV and hMPV in immunocompromised patients Source: Annual Congress 2013 –Viral infections Year: 2013